1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR
- 18 November 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (3) , 765-770
- https://doi.org/10.1016/j.bmcl.2004.11.009
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Nonpeptidic Sulfonamide Inhibits the p53−mdm2 Interaction and Activates p53-Dependent Transcription in mdm2-Overexpressing CellsJournal of Medicinal Chemistry, 2004
- Helical β-Peptide Inhibitors of the p53-hDM2 InteractionJournal of the American Chemical Society, 2004
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- Control of apoptosis by p53Oncogene, 2003
- Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumorsOncogene, 2002
- The initial evaluation of non-peptidic small-molecule HDM2 inhibitors based on p53–HDM2 complex structureCancer Letters, 2002
- Chalcone Derivatives Antagonize Interactions between the Human Oncoprotein MDM2 and p53Biochemistry, 2000
- Discovery of Potent Antagonists of the Interaction between Human Double Minute 2 and Tumor Suppressor p53Journal of Medicinal Chemistry, 2000
- p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesisHuman Mutation, 1999
- The MDM2 gene amplification databaseNucleic Acids Research, 1998